Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05493722 · ClinicalTrials.gov registry record · Early Phase 1
Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy
A Early Phase 1 study of Deep Brain Stimulation and Refractory Epilepsy, sponsored by University of Minnesota.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05493722 is a Early Phase 1 study of Deep Brain Stimulation and Refractory Epilepsy that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 20 participants, below the 815-participant average among 15 other Deep Brain Stimulation trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05493722, a Early Phase 1 study of Deep Brain Stimulation and Refractory Epilepsy, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Deep brain stimulation (DBS) is used to treat epilepsy in cases where patients are medically refractory and are not candidates for surgical resection. This therapy has been shown to be effective in seizure reduction, yet very few patients achieve the ultimate goal of seizure freedom. Implantable neural stimulators (INSs) have many parameters that may be adjusted, and could be tuned to achieve very patient specific therapies. This study will develop a platform for stimulation setting optimization based on power spectral density (PSD) measures.
Conditions Studied
Interventions
- OTHER PS and OS stimulation order 1
- OTHER PS and OS stimulation order 2
- OTHER PS and OS stimulation order 3
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-09-15 |
| Est. Completion | 2030-01-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05493722
The ClinicalTrials.gov registry entry for NCT05493722 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 815-participant average among 15 other Deep Brain Stimulation trials with a reported enrollment target (98% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Deep Brain Stimulation appearing as the primary indexed condition, and to 3 interventions - of which PS and OS stimulation order 1 is the first listed.
NCT05493722 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05493722 about?
NCT05493722 is a clinical study titled "Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy". Deep brain stimulation (DBS) is used to treat epilepsy in cases where patients are medically refractory and are not candidates for surgical resection. This therapy has been shown to be effective in seizure reduction, yet very few patients achieve the ultimate goal of seizure freedom. Implantable neu...
What is the current status of trial NCT05493722?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2023-09-15. Estimated completion is 2030-01-15.
What conditions does trial NCT05493722 study?
This clinical trial studies the following conditions: Deep Brain Stimulation, Refractory Epilepsy.
What interventions are being tested in trial NCT05493722?
The interventions under investigation include: PS and OS stimulation order 1 (OTHER), PS and OS stimulation order 2 (OTHER), PS and OS stimulation order 3 (OTHER).
Who is sponsoring clinical trial NCT05493722?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05493722 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Deep Brain Stimulation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Biomarkers of FOG Response to DBS
RECRUITING · Phase 4
-
Use of CereGate Therapy for Freezing of Gait in PD
RECRUITING · NA
-
Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia
RECRUITING · NA
-
Udall Project 1 Aim 4
RECRUITING
-
Sleep-specific DBS Therapy in Parkinson's Disease
RECRUITING · NA
-
A Study of Buntanetap in Participants With PD
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.